Aravive, Inc. — Form D

Aravive, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-28. The offering totals $41.6M, of which $41.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Fredric N EshelmanDirectorDurham, NC
Amato B GiacciaDirectorHouston, TX
Peter TC HoDirectorHouston, TX
John A HohneckerDirectorHouston, TX
Sigurd C KirkDirectorHouston, TX
Gail McIntyreDirectorHouston, TX
MICHAEL W ROGERSDirectorNEW YORK, NY
Eric B ZhangDirectorHouston, TX
Leonard Scott DoveExecutive OfficerHouston, TX
Fredric N EshelmanExecutive OfficerDurham, NC
Robert B GellerExecutive OfficerHouston, TX
Rudy N HowardExecutive OfficerHouston, TX
Gail McIntyreExecutive OfficerHouston, TX
JEFFREY CLELANDDirectorBALTIMORE, MD
JEFFREY CLELANDExecutive OfficerBALTIMORE, MD
Shahzad MalikDirectorSan Diego, CA
Michael DybbsDirectorHalf Moon Bay, CA
Srinivas AkkarajuDirectorPalo Alto, CA
Kevin JohnsonDirectorSan Diego, CA
Francesco De RubertisDirectorCharlottesville, VA
Anthony SunDirectorApex, NC
Jay ShepardDirectorDallas, TX
Volker SchellenbergerDirectorSouth San Francisco, CA
Joshua BrummExecutive OfficerWaltham, MA
Edmon JenningsDirectorRedwood City, CA

Other filings by this issuer (7)

FiledFormOfferingSold
2014-02-20D$55.0M$55.0M
2014-02-19D$10.0M$10.0M
2013-10-11D$10.0M$10.0M
2013-07-22D$12.5M$12.5M
2013-01-28D$20.5M$8.0M
2013-01-28D$4.6M$4.6M
2011-03-09D$21.1M$14.4M

More